Concourse Financial Group Securities, Inc. Inventiva S.A. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
21 transactions
Others Institutions Holding IVA
# of Institutions
16Shares Held
5.11MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$10.5 Million3.98% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$5.79 Million0.52% of portfolio
-
Bvf Inc San Francisco, CA686KShares$2.72 Million0.21% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny112KShares$443,6380.0% of portfolio
-
Commonwealth Equity Services, LLC64.9KShares$256,8330.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $167M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...